CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
National Strategy for Critical and Emerging Technologies (2020)
Author
The White House of President Donald Trump
Publication venue
The White House of President Donald Trump
Publication date
01/11/2022
Field of study
Get PDF
The Australian National University
Executive Order on Preventing Online Censorship (2020)
Author
The White House of President Donald Trump
Publication venue
The White House of President Donald Trump
Publication date
01/11/2022
Field of study
No full text
The Australian National University
New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015
Author
Centers for Disease Control and Prevention: Trends in deaths involving heroin and synthetic opioids excluding methadone and law enforcement drug product reports, by census region — United States, 2006–2015
Centers for Disease Control and Prevention: Vital signs: overdoses of prescription opioid pain relievers---United States 1999--2008
+9Â more
Drug Enforcement Administration Department of Justice
Epidemic: Responding to America’s prescription drug abuse crisis
National Pain Strategy: A comprehensive population health-level strategy for pain
Opioid abuse in the US and HHS actions to address opioid-drug related overdoses and deaths
The Joint Commission: Joint Commission Statement on Pain Management
The White House Office of the Press Secretary: President Donald J. Trump is taking action on drug addiction and the opioid crisis. The White House
U.S. Census Bureau Population Division
U.S. Department of Health and Human Services: Opioid abuse in the US and HHS actions to address opioid-drug related overdoses and deaths
U.S. Food and Drug Administration: Drugs@FDA: FDA approved drug products
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref